Harunobu Mukaiyama - Concepedia

Author

Harunobu Mukaiyama

Kissei Pharmaceutical (Japan)

Also Known As

H. MUKAIYAMA, H. Mukaiyama, Harunobu Mukaiyama

Publications

430

Citations

H-Index

Concepts

All Affiliations

Kissei Pharmaceutical (Japan)

About

Harunobu Mukaiyama is an author at Kissei Pharmaceutical (Japan) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	278
2	Biochemistry	7	7	275
3	Natural Sciences	6	6	232
4	Engineering	1	1	10
5	Biomolecular Engineering	1	1	10

Harunobu Mukaiyama

Publications

403

Citations

H-Index

Page 1

	Year	Citations
The importance of CH/π hydrogen bonds in rational drug design: An ab initio fragment molecular orbital study to leukocyte-specific protein tyrosine (LCK) kinase Tomonaga Ozawa, Eiichi Tsuji, Motoyasu Ozawa, Bioorganic & Medicinal Chemistry Drug TargetBiochemistryDrug DesignMedicineNatural Sciences	2008	73
Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke Harunobu Mukaiyama, Toshihiro Nishimura, Satoko Kobayashi, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistryC-src Inhibitory ActivityMedicineNatural Sciences	2006	53
Novel pyrazolo[1,5-a]pyrimidines as c-Src kinase inhibitors that reduce IKr channel blockade Harunobu Mukaiyama, Toshihiro Nishimura, Satoko Kobayashi, Bioorganic & Medicinal Chemistry BiochemistryMedicinePharmacological AgentPharmacotherapyAnti-cancer Agent	2007	43
A novel Syk family kinase inhibitor: Design, synthesis, and structure–activity relationship of 1,2,4-triazolo[4,3-c]pyrimidine and 1,2,4-triazolo[1,5-c]pyrimidine derivatives Akihito Hirabayashi, Harunobu Mukaiyama, Hiroaki Kobayashi, Bioorganic & Medicinal Chemistry Structure–activity RelationshipMolecular PharmacologyMedicinal ChemistryBiochemistryMedicine	2008	41
Structure–activity relationship studies of imidazo[1,2-c]pyrimidine derivatives as potent and orally effective Syk family kinases inhibitors Akihito Hirabayashi, Harunobu Mukaiyama, Hiroaki Kobayashi, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryDerivativesBiochemistryMedicine	2008	34
Discovery of Novel 2-Anilinopyrazolo[1,5-a]pyrimidine Derivatives as c-Src Kinase Inhibitors for the Treatment of Acute Ischemic Stroke Harunobu Mukaiyama, Toshihiro Nishimura, Hiroaki Shiohara, Chemical and Pharmaceutical Bulletin	2007	31
Relationship between Stereochemistry and the β<sub>3</sub>-Adrenoceptor Agonistic Activity of 4‘-Hydroxynorephedrine Derivative as an Agent for Treatment of Frequent Urination and Urinary Incontinence Nobuyuki Tanaka, Tetsuro Tamai, Harunobu Mukaiyama, Journal of Medicinal Chemistry	2002	30
Discovery of Novel<i>N</i>-Phenylglycine Derivatives as Potent and Selective β<sub>3</sub>-Adrenoceptor Agonists for the Treatment of Frequent Urination and Urinary Incontinence Nobuyuki Tanaka, Tetsuro Tamai, Harunobu Mukaiyama, Journal of Medicinal Chemistry	2001	29
Renal biopsy criterion in children with asymptomatic constant isolated proteinuria Takashi Hama, Koichi Nakanishi, Yuko Shima, Nephrology Dialysis Transplantation	2012	25
Structure–activity relationship studies of 5-benzylaminoimidazo[1,2-c]pyrimidine-8-carboxamide derivatives as potent, highly selective ZAP-70 kinase inhibitors Akihito Hirabayashi, Harunobu Mukaiyama, Hiroaki Kobayashi, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryDrug TargetBiochemistry	2008	21

Page 1